Breadcrumb Learning and development Fellowships Technical Fellowships 2019 Technical Fellowship Awardees 2019 Technical Fellowship Awardees - Dr. Siew Yim Loh, University of Malaya, Kuala Lumpur, Malaysia Host Institution: University of Southampton, Southampton, United Kingdom Patient support, survivorship and palliative care at Macmillan Research Centre ...................................................... Syed Jawad Ali Shah, Institute of Radiotherapy and Nuclear Medicine, Peshawar, Pakistan Host Institution: CancerCare Manitoba, Manitoba, Canada Volumetric Modulated Arc Therapy (VMAT) Planning for Head and Neck Cancers ...................................................... Dr. Haydee Cristina Verduzco-Aguirre, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico Host Institution: University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, United States Research Observership in Geriatric Oncology ...................................................... Ms. Florence Manjuh, Cameroon Baptist Convention Health Services, Younde, Cameroon Host Institution: Information and Research Center - King Hussein Foundation, Amman, Jordan Setting up a Breast cancer program within the CBCHS in Cameroon ...................................................... Mr. Mbiydzenyuy Ferdinant Sonyuy, Cameroon Baptist Convention Health Services, Younde, Cameroon Host Institution: Information and Research Center - King Hussein Foundation, Amman, Jordan Setting up a comprehensive Breast Cancer Program in Cameroon ...................................................... Dr Anindita Dutta, Tata Medical Center, Kolkata, India Host Institution: University of Manchester, Manchester, United Kingdom Understanding Optimal Conditions For Establishing Reproducible Primary Tumour Organoid ...................................................... Dr Eudoxia Hatzivassiliou, Aristotle University of Thessaloniki, Thessaloniki, Greece Host Institution: Hubrecht Institute, Utrecht, Netherlands Investigation of the role of tumor suppressor CYLD in human breast cancer ...................................................... Ijeoma Uzoma, College of Medicine, University of Nigeria, Enugu, Nigeria Host Institution: University of Siena, Siena, Italy Immunohistochemical characterisation and genomic profiling of lymphomas in Nigeria ...................................................... Dr. Manit Gundavda, PD Hinduja National Hospital, Mumbai, India Host Institution: The Royal Orthopaedic Hospital, Birmingham, United Kingdom High Prevalence of Vitamin D Deficiency in Patients with Bone Tumors: Genomic profiling of Vitamin D Receptor (VDR) ...................................................... Dr Tala Shekarian, University Hospital Basel, Basel, Switzerland Host Institution: Stanford University School of Medicine, California, United States High-dimensional analysis of microglial drug response in glioblastoma bioreactors ...................................................... Dr. Fernanda Oliveira, A.C. Camargo Cancer Center, São Paulo, Brazil Host Institution: Sylvester Comprehensive Cancer Center/University of Miami Health Systems, Miami, United States Cancer drug incremental cost-effectiveness: systematic review and meta-analysis ...................................................... Dr Razinah Sharif, Universiti Kebangsaan Malaysia, Malaysia Host Institution: International Agency for Research on Cancer, Lyon, France Transfer of knowledege and skill needed in metabolomics profiling and cancer mediators for colorectal cancer survivors in Malaysia ...................................................... Ms Swapna Lilly Cyriac, KIMS Cancer Care and Research Center, Trivandrum, India Host Institution: Northwell Health Center for Advanced Medicine (CFAM), New York, United States SBRT Planning: A Focus on Treatment Techniques and its Dosimetric Aspects ...................................................... Dr. Filippo Piccinini, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy Host Institution: Biological Research Centre of the Hungarian Academy of Sciences, Szeged, Hungary 3D-CELL-ANNOTATOR for single-cell phenotyping of cancer 3D spheroids ...................................................... Dr. Shubham Garg, Max Superspeciality Hospital, Ghaziabad, India Host Institution: The Pulmonary Hospital, Zakopane, Poland Transcervical Approach to Staging and Management of Lung Cancer ...................................................... Dr. Ahmed Abugharib, Sohag Faculty of Medicine, Egypt Host Institution: Centre Leon Berard, Lyon, France Molecular imaging using 18FDG-PET/CT for radiation therapy planning of head and neck cancers ...................................................... Dr. Aymone Gurtner, Regina Elena National Cancer Institute, Rome, Italy Host Institution: Institute of Cancer Research, London, United Kingdom Set-up and use of Patient-Derived Organoid to identify prognostic biomarkers ...................................................... Dr. Ahmed Mohamed Abdelaziz Abdellatif, Medical Research Institute Alexandria University, Alexandria, Egypt Host Institution: George Washington University, Washington DC, United States Innovative surgical management of thoracic malignancies observership ...................................................... Dr Naveen Khargekar, Homi Bhabha Cancer Hospital, Varanasi, India Host Institution: National Cancer Institute, NIH NCI Division of Cancer Epidemiology and Genetics, Rockville, United States Individual mentorship training on cervical cancer etiology, biology, screening and precancer treatment ...................................................... Dr Muibat Haruna, Lagos University Teaching Hospital, Lagos, Nigeria Host Institution: Queen Elizabeth Hospital, Birmingham, United Kingdom Androgen receptor expression in triple negative breast cancer at the Lagos University Teaching Hospital ...................................................... Dr. Slava Kopetskyi, National Cancer Institute MPH of Ukraine Host Institution: Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom Development of peritoneal carcinomatosis treatment program in low-middle income country ...................................................... Dr Mayur Mayank, Apollo Hospital Bangalore, Bangalore, India Host Institution: Petermac MacCallum Cancer Centre, Melbourne, Australia SABR in Oligometastatic Disease ...................................................... Dr. Alvaro Ronco, Instituto de Radiología y Centro de Lucha Contra el Cáncer, Montevideo, Uruguay Host Institution: Instituto de Salud Carlos III de Madrid, Spain Dietary iron types and breast cancer risk in the MCC-Spain Study ...................................................... Dr Srabani Mittal, Cancer Foundation of India, Kolkata, India Host Institution: International Agency for Research on Cancer, Lyon, France Preparation of an online digital atlas on VIA and ablative treatment, and creation of an image library to support development of artificial intelligence in visual detection of cervical abnormalities ...................................................... Dr Anthonia Sowunmi, University Of Lagos, Lagos, Nigeria Host Institution: The University of Chicago, Chicago, United States Experiential study of breast cancer clinical trials in a tertiary institution (University of Chicago) ...................................................... Mr. Biswajoy Pal, Tata Medical Center, Kolkata, India Host Institution: Imperial College London, London, United Kingdom Molecular diagnosis and monitoring of BCR-ABL positive leukemia ...................................................... Dr. Chantal Matar, University of Ottawa, Canada Host Institution: International Agency for Research on Cancer, Lyon, France Chemoprevention signature of probiotics in microbiome regulation of microRNAs expression in the gut and the mammary gland: link between early manipulation of gut microbiome and breast cancer. ...................................................... Dr Seema Singhal, All India Institute of Medical Sciences, New Delhi, India Host Institution: Memorial Sloan-Kettering Cancer Center, New York, United States Sentinel lymph node mapping in patients with Endometrial carcinoma ...................................................... Dr Dillip Muduly, All India Institute of Medical Sceinces, Bhubaneswar, India Host Institution: Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Methods of Cytoreductive surgery and Hyperthermic intraperitoneal chemotherapy (HIPEC) for Peritoneal Carcinomatosis (PC) ...................................................... Dr Katarina Rejlekova, National Cancer Institute, Comenius University, Bratislava, Slovak Republic Host Institution: Memorial Sloan Kettering Cancer Center, New York, United States Choriocarcinoma syndrome in testicular germ cell tumors ...................................................... Dr. Deep Shankar Pruthi, Action Cancer Hospital, New Dehli, India Host Institution: Jules Bordet Institute, Brussels, Belgium Stereotactic Radiotherapy for management of thoracic and CNS malignancies ...................................................... Dr. Lateef Adebisi Odukoya, Lagos University Teaching Hospital, Lagos, Nigeria Host Institution: University of Chicago, Chicago, United States Immunohistochemical study and clinicopathologic correlation of COX-2 and HER-2 expression in colorectal carcinoma: a 5-year retrospective study ...................................................... Dr Shagun Misra, Sanjay Gandhi Post-graduate Institute of Medical Sciences, Lucknow, India Host institution: University of Pennsylvania, Philadelphia, United States Identifying challenges and setting up a SBRT programme in liver tumors at a tertiary care institution ...................................................... Dr Andreea Marza, Clinic of Pulmonary Diseases, Iasi, Romania Host Institution: Civil Hospital of Brescia, Brescia, Italy Developing diagnostic skills in pleural biopsy for pleural tumors management ...................................................... Dr Bindu Krishnappa Venugopal, Kidwai Cancer Institute, Bengaluru, India Host Institution: Petermac MacCallum Cancer Centre, Melbourne, Australia To learn and implement stereotactic ablative radiation therapy in the treatment of lung cancer ...................................................... Mr Tarek Mohamed Zaghloul, Children's Cancer Hospital Egypt, Cairo, Egypt Host Institution: St. Jude Children’s Research Hospital, Memphis, United States Laparoscopic Surgical Managment of Pediatric Tumours ...................................................... Dr Vipul Nautiyal, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India Host Institution: Christie School of Oncology, Manchester, United Kingdom Re-irradiation of head and neck cancer in the era of Advance technique (IMRT, IGRT & SBRT): patient selection, imaging, technical aspects and current evidence ...................................................... Dr JC Kennetth Jacinto, Benavides Cancer Institute, University of Santo Toma, Manila, Philippines Host Institution: H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States Holistic Management of Head and Neck Cancers through Multidisciplinary Approach ...................................................... Mr Saad Bin Saeed Ahmed, Aga Khan University, Pakistan Host Institution: Hokkaido University Hospital, Sapporo, Japan Acquiring skills and knowledge on modern treatment planning and delivery techniques in radiotherapy ...................................................... Dr Fan Chai, First Hospital of Army Medical University, Chongqing, China Host Institution: Organisation for Oncology and Translational Research, Hong Kong The application and translational research of targeted drugs in advanced breast cancer ...................................................... Dr Jian Chen, Hubei Cancer Hospital, Wuhan, China Host Institution: National Cancer Institute, Center for Cancer Research, Bethesda, United States Preclinical experiments and techniques in head and neck cancer models ...................................................... Dr Jiangyuan Yu, Peking University Cancer Hospital & Institut, Beijing, China Host Institution: Zentralklinik Bad Berka, Bad Berka, Germany Clinical application of peptide receptor radionuclide therapy in neuroendocrine neoplasms ...................................................... Dr Yubei Huang, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China Host Institution: International Agency for Research on Cancer (IARC), Lyon, France Cross-sectional studies on the associations between cancer screening beliefs, knowledge, mental health, and behaviors ...................................................... Dr Jing Liu, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China Host Institution: University Health Network, Toronto, Canada Clinical Observership of Breast Reconstruction ...................................................... Dr Jun Li, Henan Cancer Hospital, Zhengzhou, China Host Institution: Mayo Clinic, Rochester, United States BRCA pathogenic mutations in the progenitor cells contribute to the carcinogenesis, treatment response and prognosis of ovarian cancer ...................................................... Dr Yuanyuan Lu, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China Host Institution: Vanderbilt University Medical Center (VUMC), Nashville, United States Mechanisms of Epigenetic Regulation of Drug Resistance in Cancer ...................................................... Dr Xiaolei Wei, Nanfang Hospital, Southern Medical University, Guangzhou, China Host Institution: Center for Genomic Regulation, Barcelona, Spain xCT Inhibition Confers Chemoresistance in the ABC Subtype of Diffuse Large B cell lymphoma ...................................................... Dr Yiming Meng, Liaoning Province Cancer Hospital, Shenyang, China Host Institution: Johns Hopkins University-School of Medicine, Baltimore, United States Weakening the extent of the damage of chemotherapy drugs on nerve cells ...................................................... Dr Akhilanand Chaurasia, King George's Medical University, Lucknow, India Host Institution: Guy's, King's and St Thomas, school of Medicine and Dentistry, London, United Kingdom A comparative evaluation of circulatory and salivary miRNA’s as diagnostic biomarkers in Precancerous and Cancerous Lesions of Oral Cavity-A prospective case control study ...................................................... Dr Kavitha Jain, Tata Memorial Centre, Mumbai, India Host Institution: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy Clinical fellowship/observership - cancer treatment - multidisciplinary management of soft tissue sarcomas ...................................................... Dr Soniya Dulal, National Academy of Medical Sciences, Kathmandu, Nepal Host Institution: Princess Margaret Cancer Centre, Toronto, Canada Multidisciplinary management of advanced/ incurable lung cancer ...................................................... Mr Lambert Christophe Safari, Muhimbili University Health and Allied Sciences, Dar-Es-Salaam, Tanzania Host Institution: University of California, San Francisco, United States Acquiring advanced skills in supportive care delivery to improve quality of life in cancer patients ...................................................... Dr Suraj Hindiskere, HCG Cancer Centre, Bangalore, India Host Institution: Istituto Ortopedico Rizzoli, Bologna, Italy Fellowship in Orthopaedic Oncology ...................................................... Dr Arun Pandey, Geetanjali Medical College and Hospital, Udaipur, India Host Institution: Memorial Sloan Kettering Cancer Center, New York, United States Hepatobiliary Cancer Surgery Observership ...................................................... Dr Kunal Oswal, Tata Education Development Trusts, Mumbai, India Host Institution: International Agency for Research on Cancer, Lyon, France UICC- IARC Development Fellowship: Evaluation of breast, cervix and oral cancer screening policies and implementation in India ...................................................... Mr Rongshou Zheng, National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China Host Institution: International Agency for Research on Cancer, Lyon, France UICC-IARC Development Fellowship: Assessing the impact of risk factor changes and population aging on future cancer burden in China ...................................................... Dr Ivana Blazic, Clinical Hospital Center Zemun, Belgrade, Serbia Host Institution: Instituto Alexander Fleming, Buenos Aires, Argentina Epidemiological, pathological, clinical and imaging features of colorectal cancer in young adults ...................................................... Dr Sudha Padmam, Regional Cancer Centre, Trivandrum, India Host Institution: Cancer Treatment Centers of America , Tulsa, United States Safer and nonaddictive cancer pain management in the current era of opioid epidemic in cancer patients ...................................................... Eveline Tata Mayaah, Humanity at Heart International Association, Douala, Cameroon Host Institution: Women4cancer early detection and treatment, Nairobi, Kenya Public health: Cancer Prevention and Advocacy ...................................................... Dr María Graciela Abriata, Agency for Cancer Control of Santa Fe, Rosario, Argentina Host Institution: International Agency for Research on Cancer, Lyon, France UICC-IARCDEVFEL – Improving cancer surveillance in Latin America through tailored training material and status analysis ...................................................... Last update Thursday 12 January 2023 Share this page